Nova Southeastern University is a private research university with its main campus in Davie, Florida. The university consists of 18 total colleges, centers, and schools offering over 150 programs of study.

During the past decade, Nova Southeastern University conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nova Southeastern University" #1 sponsor was "Nova Southeastern University" with 7 trials, followed by "Amylyx Pharmaceuticals Inc." with 1 trials sponsored, "Centers for Disease Control and Prevention" with 1 trials sponsored, "Dentsply Sirona Implants and Consumables" with 1 trials sponsored and "Eisai Inc." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nova Southeastern University" #1 collaborator was "Nova Southeastern University" with 3 trials as a collaborator, "Boston University" with 1 trials as a collaborator, "Carl Zeiss Meditec, Inc." with 1 trials as a collaborator, "Centers for Disease Control and Prevention" with 1 trials as a collaborator and "DePaul University" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Nova Southeastern University" are "HIV Infections" (2 trials), "Alcohol Consumption" (1 trials), "Amyotrophic Lateral Sclerosis" (1 trials), "Basal Cell Carcinoma" (1 trials) and "Chronic Fatigue Syndrome (CFS)" (1 trials). Many other conditions were trialed in "Nova Southeastern University" in a lesser frequency.

Most popular intervention types in "Nova Southeastern University" are "Drug" (5 trials), "Device" (3 trials), "Behavioral" (2 trials), "Dietary Supplement" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "AMX0035" (1 trials), "ANKYLOS C/X 6.6 mm" (1 trials), "Abutment with concave subcritical contour" (1 trials) and "Abutment with convex subcritical contour" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nova Southeastern University" are 14 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Nova Southeastern University". 1 are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Nova Southeastern University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Nova Southeastern University, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".

Nova Southeastern University has several departments that took part in Clinical trials: "Nova Southeastern University College of Optometry" - 10 trials, "NSU Psychiatry Research Office" - 2 trials, "Nova Southeastern University, College of Pharmacy" - 2 trials, "Nova Southeastern University, College of Dental Medicine" - 2 trials